表紙:微生物発酵技術の市場規模、シェア、動向分析レポート:用途別(抗生物質、ワクチン)、最終用途別(バイオ製薬会社)、地域別、セグメント別予測、2022年~2030年
市場調査レポート
商品コード
1147468

微生物発酵技術の市場規模、シェア、動向分析レポート:用途別(抗生物質、ワクチン)、最終用途別(バイオ製薬会社)、地域別、セグメント別予測、2022年~2030年

Microbial Fermentation Technology Market Size, Share & Trends Analysis Report By Application (Antibiotics, Vaccines), By End-use (Biopharmaceutical Companies), By Region, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 170 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
微生物発酵技術の市場規模、シェア、動向分析レポート:用途別(抗生物質、ワクチン)、最終用途別(バイオ製薬会社)、地域別、セグメント別予測、2022年~2030年
出版日: 2022年10月04日
発行: Grand View Research
ページ情報: 英文 170 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

微生物発酵技術市場の成長と動向

グランドビューリサーチ社の最新レポートによると、微生物発酵技術の世界市場規模は2030年までに494億米ドルに達すると予測されています。この市場は、2022年から2030年にかけてCAGR6.0%で拡大すると予測されています。発酵はバイオ医薬品の製造において最も重要であると観察されているため、バイオ医薬品製造における微生物発酵技術に対する需要も高まっています。このため、この市場空間では、共同研究や開発が増加しています。

例えば、2021年9月、BIOVECTRAとABECは共同で、BIOVECTRAの製造能力を拡大するために後者企業がCSRシングルユースの微生物発酵ソリューションを提供すると発表しました。新たに導入されたソリューションは、高成長の微生物発酵を大規模に行い、より速いターンアラウンドタイムを提供することが期待されます。さらに、2022年9月、カーギルとジェノマティカはサイクロンエンジニアとともに、バイオリアクターの発酵処理をスケールアップするプロジェクトに取り組んでいます。このプロジェクトは、250万米ドルの助成金を受けた「ナショナル・バイオテクノロジー・アンド・バイオマニュファクチャリング・イニシアチブ」の一部です。

さらに、微生物発酵プラットフォームの技術的進歩も、市場の成長を補完すると予想されます。例えば、複雑な生物製剤や低分子の生産に使用される微生物細胞工場の性能を強化するために、いくつかの代謝工学的アプローチが研究者によって開発されています。この市場空間におけるこうした継続的な開発により、バイオマニュファクチャリングにおけるこの技術の採用が増加すると考えられます。

さらに、ホルモン、抗体フラグメント、肺炎球菌ワクチンなど、さまざまな医薬品やワクチンが、微生物発酵技術を使用してバイオ製造されています。バクテリアの細胞はせん断に対して抵抗力があるため、高せん断ラジアルインペラーシステムと高い撹拌速度が使用できます。これにより、発酵槽は高い物質移動能力を持ち、代謝の速い高細胞密度の微生物細胞の培養に対応できるようになり、バイオプロセスで生産できる製品の量が増加するのです。このように、細菌発酵にSUB発酵槽の採用が進んでいることから、市場は今後数年間で大きな成長を遂げる可能性があります。

微生物発酵技術市場レポートハイライト

用途別では、2021年に抗生物質分野が最も高い市場収益シェアを獲得しました。抗生物質耐性微生物の増加による研究活動の増加が、市場成長にプラスの影響を及ぼしている

微生物の迅速かつ安定した成長パターンにより、低分子合成における発酵の使用は、予測期間を通じて有利な成長を示すことが期待されます。

エンドユーザー別では、2021年にCMOとCDMOが大きなシェアを占めています。複数のCMOによる生産能力の拡大やアウトソーシングの動向は、このセグメントの売上高を押し上げると予想されます。

インド、日本、中国などの国々では、CMOの稼働数が多く、バイオ医薬品産業が成長しているため、2021年にはアジア太平洋地域が市場を独占しました。

さらに、日本では生物製剤やバイオ医薬品の需要が高まっています。その結果、日本企業は国内のバイオ製造事業を強化するために、さまざまな戦略的イニシアチブをとっています。

北米は、確立されたバイオ医薬品産業の存在と発酵ソリューションプロバイダーの多さから、予測期間を通じて最も速い成長を遂げると予想されます。

主要企業による製品提供の継続的な改善努力も北米市場の成長に寄与しています。

目次

第1章 調査手法と範囲

  • 調査の仮定
  • 調査手法
  • 情報調達
    • 微生物発酵技術市場に関する調査のサンプルサイズ:
      • 一次情報
      • セカンダリデータソース
  • 情報またはデータ分析
  • 市場の策定と検証
  • 世界市場:CAGR計算
  • 目的

第2章 エグゼクティブサマリー

  • 市場概要、2021年
  • 市場セグメンテーション
  • 競争環境

第3章 市場変数、動向、および範囲

  • 市場力学
    • 市場促進要因分析
      • さまざまな業界で発酵技術由来製品の利用が増加
      • 発酵技術のさまざまな分野における研究開発活動の増加
      • 化石燃料の枯渇とガソリン価格の上昇
    • 市場抑制要因分析
      • 微生物発酵に伴う技術的課題
  • 2021年のアプリケーションの浸透と成長の見通しマッピング(100万米ドル)
  • COVID-19影響分析
  • 事業環境分析
    • SWOT分析;要因別(政治と法律、経済、技術)
    • ポーターのファイブフォース分析

第4章 微生物発酵技術市場:アプリケーションビジネス分析

  • 微生物発酵技術市場:アプリケーションの変動分析
  • 抗生物質
  • プロバイオティクスサプリメント
  • モノクローナル抗体
  • 組換えタンパク質
  • バイオシミラー
  • ワクチン
  • 酵素
  • 小分子
  • その他

第5章 微生物発酵技術市場:エンドユーザービジネス分析

  • 微生物発酵技術市場:エンドユーザーの変動分析
  • バイオ医薬品企業
  • 受託調査機関(CRO)
  • CMO &CDMO
  • 学術・調査機関

第6章 微生物発酵技術市場:地域ビジネス分析

  • 微生物発酵技術市場:地域変動分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第7章 企業プロファイル

  • 企業プロファイル
    • BIOCON LTD.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • BIOVECTRA INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • DANONE UK
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • F. HOFFMANN-LA ROCHE LTD
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • KONINKLIJKE DSM NV
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • LONZA
      • 会社概要
      • ポール株式会社
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • NOVOZYMES A/S
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • TERRAVIA HOLDINGS, INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • BIOZEEN
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. North America microbial fermentation technology market, by country, 2018 - 2030 (USD Million)
  • Table 3. North America microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 4. North America microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 5. U.S. microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 6. U.S. microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 7. Canada microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 8. Canada microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 9. Europe microbial fermentation technology market, by country, 2018 - 2030 (USD Million)
  • Table 10. Europe microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 11. Europe microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 12. Germany microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 13. Germany microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 14. U.K. microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 15. U.K. microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 16. France microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 17. France microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 18. Italy microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 19. Italy microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 20. Spain microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 21. Spain microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 22. Asia Pacific microbial fermentation technology market, by country, 2018 - 2030 (USD Million)
  • Table 23. Asia Pacific microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 24. Asia Pacific microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 25. China microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 26. China microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 27. Japan microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 28. Japan microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 29. India microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 30. India microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 31. South Korea microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 32. South Korea microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 33. Australia microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 34. Australia microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 35. Latin America microbial fermentation technology market, by country, 2018 - 2030 (USD Million)
  • Table 36. Latin America microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 37. Latin America microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 38. Brazil microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 39. Brazil microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 40. Mexico microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 41. Mexico microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 42. MEA microbial fermentation technology market, by country, 2018 - 2030 (USD Million)
  • Table 43. MEA microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 44. MEA microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 45. South Africa microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 46. South Africa microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 47. Saudi Arabia microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 48. Saudi Arabia microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)
  • Table 49. UAE microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
  • Table 50. UAE microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Information procurement
  • Fig. 3. Primary research pattern
  • Fig. 4. Market research approaches
  • Fig. 5. Value-chain-based sizing & forecasting
  • Fig. 6. QFD modeling for market share assessment
  • Fig. 7. Market formulation & validation
  • Fig. 8. Microbial fermentation technology market snapshot, 2021 (USD Million)
  • Fig. 9. Market segmentation
  • Fig. 10. Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11. Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12. Penetration and growth prospect mapping
  • Fig. 13. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14. Porter's Five Forces Analysis
  • Fig. 15. Microbial fermentation technology market: Application outlook and key takeaways
  • Fig. 16. Microbial fermentation technology market: Application movement analysis
  • Fig. 17. Global antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18. Global probiotics supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19. Global monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20. Global recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21. Global biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22. Global vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23. Global enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24. Global small molecules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25. Global other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26. Microbial fermentation technology market: End-user outlook and key takeaways
  • Fig. 27. Microbial fermentation technology market: End-user movement analysis
  • Fig. 28. Microbial fermentation technology market for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 29. Microbial fermentation technology market for contract research organizations, 2018 - 2030 (USD Million)
  • Fig. 30. Microbial fermentation technology market for CMOs & CDMOs, 2018 - 2030 (USD Million)
  • Fig. 31. Microbial fermentation technology market for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 32. Microbial fermentation technology market: Regional outlook and key takeaways
  • Fig. 33. Microbial fermentation technology market: Regional movement analysis
  • Fig. 34. North America microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 35. U.S. microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 36. Canada microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 37. Europe microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 38. Germany microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 39. U.K. microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 40. France microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 41. Spain microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 42. Italy microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 43. Asia Pacific microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 44. China microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 45. Japan microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 46. India microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 47. South Korea microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 48. Australia microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 49. Latin America microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 50. Brazil microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 51. Mexico microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 52. MEA microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 53. South Africa microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 54. Saudi Arabia microbial fermentation technology market, 2018 - 2030 (USD Million)
  • Fig. 55. UAE microbial fermentation technology market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-983-0

Microbial Fermentation Technology Market Growth & Trends:

The global microbial fermentation technology market size is expected to reach USD 49.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2022 to 2030. Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.

For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA's manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale. Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.

Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.

Additionally,various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates. This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.

Microbial Fermentation Technology Market Report Highlights:

  • Based on application, the antibiotics segment captured the highest market revenue share in 2021. Increasing research activities due to the rise of antibiotic-resistant microbes have positively impacted market growth
  • Owing to the faster and stable growth pattern of microorganisms, the use of fermentation in small molecule synthesis is expected to witness a lucrative growth throughout the forecast period
  • By end-users, CMOs and CDMOs accounted for a significant share in 2021. The capacity expansion by several CMOs and the growing trend of outsourcing are expected to propel the segment revenue generation
  • Asia Pacific dominated the market in 2021 owing to the high number of operating CMOs and growing biopharmaceutical industry in countries such as India, Japan, and China
  • Furthermore, the demand for biologics and biopharmaceuticals is increasing in Japan. As a result, Japanese firms are undertaking various strategic initiatives to enhance their domestic biomanufacturing operations
  • North America is anticipated to witness the fastest growth throughout the forecast period owing to the presence of a well-established biopharmaceutical industry coupled with a high number of fermentation solution providers
  • Continuous efforts by key players to improve their product offerings are also contributing to North America's regional market growth

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Assumptions
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Sample size for the study on microbial fermentation technology market:
      • 1.3.1.1 Primary Sources
      • 1.3.1.2 Secondary Data Sources
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation & Validation
  • 1.6 Global Market: CAGR Calculation
  • 1.7 Objectives
    • 1.7.1 Objective 1
    • 1.7.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Summary, 2021
  • 2.2 Market Segmentation
  • 2.3 Competitive Milieu

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing usage of fermentation technology-derived products among various industries
      • 3.1.1.2 Rising research and development activities in different fields of fermentation technology
      • 3.1.1.3 Exhausting fossil fuel reserves and rising gasoline prices
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Technological challenges associated with microbial fermentation
  • 3.2 Penetration and Growth Prospect Mapping for Application, 2021 (USD Million)
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Business Environment Analysis
    • 3.4.1 SWOT analysis; by factor (political & legal, economic, and technological)
    • 3.4.2 Porter's five forces analysis

Chapter 4 Microbial Fermentation Technology Market: Application Business Analysis

  • 4.1 Microbial Fermentation Technology Market: Application Movement Analysis
  • 4.2 Antibiotics
    • 4.2.1 Global antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3 Probiotics Supplements
    • 4.3.1 Global probiotic supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4 Monoclonal Antibodies
    • 4.4.1 Global monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5 Recombinant Proteins
    • 4.5.1 Global recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6 Biosimilars
    • 4.6.1 Global biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7 Vaccines
    • 4.7.1 Global vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.8 Enzymes
    • 4.8.1 Global enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.9 Small Molecules
    • 4.9.1 Global small molecules market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.10 Others
    • 4.10.1 Global other applications market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Microbial Fermentation Technology Market: End-User Business Analysis

  • 5.1 Microbial Fermentation Technology Market: End-user Movement Analysis
  • 5.2 Biopharmaceutical Companies
    • 5.2.1 Microbial fermentation technology market for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • 5.3 Contract Research Organizations (CROs)
    • 5.3.1 Microbial fermentation technology market for contract research organizations, 2018 - 2030 (USD Million)
  • 5.4 CMOs & CDMOs
    • 5.4.1 Microbial fermentation technology market for CMOs & CDMOs, 2018 - 2030 (USD Million)
  • 5.5 Academic & Research Institutes
    • 5.5.1 Microbial fermentation technology market for academic & research institutes, 2018 - 2030 (USD Million)

Chapter 6 Microbial Fermentation Technology Market: Regional Business Analysis

  • 6.1 Microbial Fermentation Technology Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Germany
      • 6.3.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3 U.K.
      • 6.3.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5 Spain
      • 6.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 Middle East Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Company Profiles
    • 7.1.1 BIOCON LTD.
      • 7.1.1.1 Company overview
      • 7.1.1.2 Financial performance
      • 7.1.1.3 Product benchmarking
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 BIOVECTRA INC.
      • 7.1.2.1 Company overview
      • 7.1.2.2 Financial performance
      • 7.1.2.3 Product benchmarking
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 DANONE UK
      • 7.1.3.1 Company overview
      • 7.1.3.2 Financial performance
      • 7.1.3.3 Product benchmarking
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 F. HOFFMANN-LA ROCHE LTD
      • 7.1.4.1 Company overview
      • 7.1.4.2 Financial performance
      • 7.1.4.3 Product benchmarking
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 KONINKLIJKE DSM NV
      • 7.1.5.1 Company overview
      • 7.1.5.2 Financial performance
      • 7.1.5.3 Product benchmarking
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 LONZA
      • 7.1.6.1 Company overview
      • 7.1.6.2 Pall Corporation
      • 7.1.6.3 Financial performance
      • 7.1.6.4 Product benchmarking
      • 7.1.6.5 Strategic initiatives
    • 7.1.7 NOVOZYMES A/S
      • 7.1.7.1 Company overview
      • 7.1.7.2 Financial performance
      • 7.1.7.3 Product benchmarking
      • 7.1.7.4 Strategic initiatives
    • 7.1.8 TERRAVIA HOLDINGS, INC.
      • 7.1.8.1 Company overview
      • 7.1.8.2 Financial performance
      • 7.1.8.3 Product benchmarking
      • 7.1.8.4 Strategic initiatives
    • 7.1.9 BIOZEEN
      • 7.1.9.1 Company overview
      • 7.1.9.2 Financial performance
      • 7.1.9.3 Product benchmarking